Second mRNA COVID-19 Vaccine in Primary Series Can Be Extended to 8 Weeks for Some Individuals
This guidance discusses that individuals 12 years and older can receive the second dose of the Pfizer-BioNTech vaccine 3-8 weeks after the first. Additionally, the interval for those 18 years and older for Moderna is 4-8 weeks.
CDC Study Shows mRNA Vaccination During Pregnancy Protects Infants From COVID-19
The CDC released the first real world data February 15 in a Morbidity and Mortality Weekly Report (MMWR) that infants younger than 6 months were overall 61% less likely to be hospitalized from COVID-19 if their mothers were vaccinated during pregnancy through completion of a 2-dose primary mRNA COVID-19 vaccine series with either Pfizer-BioNTech (Comirnaty) or Moderna (Spikevax).
CDC’s Advisory Committee Is Recommending Shortened Interval for COVID-19 Boosters for Immunocompromised Patients
Patients who are immunocompromised are advised to get a three-dose series and then a fourth dose.
Moderna’s COVID-19 Vaccine Receives Full FDA Approval
FDA is requiring postmarketing surveillance studies to further assess the risk of myocarditis and pericarditis from the vaccine, which is being sold under the brand name Spikevax.
Free At-Home Rapid COVID-19 Tests Available To Order Today, A Day Earlier Than Scheduled
The limit is four tests per household.
Medication Safety Considerations for COVID-19 Treatment Paxlovid
Smaller doses are recommended for people with moderate renal impairment and the treatment should not be taken by people with serious kidney disease. There are also drug interactions to be aware of because Paxlovid is an inhibitor of CYP3A.
Proposed Rule Could Make Healthcare Coverage More Affordable and Accessible for Consumers
2 Clarke Drive Cranbury, NJ 08512